Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3720877

Beta release

Statistics of Clinical relevance of high plasma trough levels of the kinase inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC patients
Statistics for this year
PeriodVisitsDownloads
20241313
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0944
2024-1055
2024-1100